Skip to main content

Table 2 Outcome variables by cohort

From: Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study

Characteristic

Independent

Pre–post

Without percepta

With percepta

Without percepta

With percepta

N = 330a

N = 337a

N = 341a

N = 341a

Next step

 Ablative therapyb

56 (17%)

150 (45%)

57 (17%)

191 (56%)

 CT

98 (30%)

40 (12%)

81 (24%)

27 (7.9%)

 Other

9 (2.7%)

1 (0.3%)

14 (4.1%)

3 (0.9%)

 Repeat biopsy

167 (51%)

146 (43%)

189 (55%)

120 (35%)

CT interval

 1 month

7 (7.1%)

2 (5.0%)

5 (6.2%)

5 (19%)

 3 months

82 (84%)

30 (75%)

66 (81%)

21 (78%)

 6 months

9 (9.2%)

8 (20%)

10 (12%)

1 (3.7%)

  1. an (%)
  2. bIncludes surgery